COAG icon

Hemab Therapeutics Hldgs (COAG)

NASDAQ

$28.46

$0.00 (

0.00%

)

1D
5D
1M
6M
1Y
5Y
Pre market

COAG: $28.46 / ₿ 0.0004 BTC / 35885 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$28.46
$23.00 - $36.61
$1.33B
-3.78
$1.00
46.71M
$24.60 - $33.14
No

What is Hemab Therapeutics Hldgs (COAG)?

Hemab Therapeutics Holdings Inc is a clinical-stage biotechnology company developing therapies for the treatment of blood coagulation disorders. It focuses on discovering, developing, and commercializing treatments for conditions such as Glanzmann thrombasthenia, Factor VII deficiency, and von Willebrand disease. Its flagship candidate, sutacimig (HMB-001), is a bispecific antibody currently in clinical trials for the prophylactic treatment of Glanzmann thrombasthenia and Factor VII deficiency. The company has one operating segment, engaged in the research and development of prophylactic therapeutics for bleeding disorders.

The Hemab Therapeutics Hldgs (COAG) stock price has been falling

The Hemab Therapeutics Holdings, Inc. Common Stock (COAG) stock pre-market price today is $28.46, reflecting a 0.00% pre-market move since the market last closed. The company’s market capitalization stands at $1.33B, with a daily trading volume of $1.00 shares. The previous closing price was $28.46.

Get started with Hemab Therapeutics Hldgs (COAG)

Ready to get started? Follow the steps below, or read our guide on how to buy Hemab Therapeutics Hldgs stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy COAG

Search for COAG in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy COAG.

COAG FAQs

COAG is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

COAG is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Hemab Therapeutics Holdings, Inc. Common Stock (COAG) has traded between a low of $23.00 and a high of $36.61.

COAG is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Hemab Therapeutics Hldgs? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
COAG icon
COAG

Only available to USA clients through the Kraken app
or Kraken Pro.

Explore other stocks

Most active

Explore the most-traded stocks today

SNAL icon

SNAL

AIIO icon

AIIO

Top gainers

Browse today’s biggest stock market winners

SNAL icon

SNAL

AIIO icon

AIIO

TBLAW icon

Top losers

Compare the worst-performing stocks of 
the day

YOTAR icon

YOTAR

STAK icon

STAK

MDXH icon

MDXH

PBMWW icon

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.